Morgan Stanley analyst Kristine Liwag lowered the firm’s price target on Northrop Grumman (NOC) to $714 from $720 and keeps an Overweight rating on the shares. The firm views Aerospace and Defense as attractive going into 2026 as demand continues to outpace supply growth, the analyst tells investors in a year-ahead note for the group.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman upgraded to Overweight from Neutral at Alembic Global
- Private Markets: Musk’s SpaceX targets 2026 IPO at valuation of $1.5T
- Roblox downgraded, Lululemon upgraded: Wall Street’s top analyst calls
- Northrop Grumman initiated with a Buy at Citi
- EchoStar jumps on SpaceX IPO talk, Morgan Stanley upgrade